A. Zribi, K. Al Riyami, H. S. Al Zahibi, and I. A. Burney, “Managing the Adverse Events Associated with the Combination Pembrolizumab and Lenvatinib Therapy in Endometrial Cancer”, Sultan Qaboos Univ Med J, vol. 1, no. 1, Sep. 2023.